Stanley N. Cohen

National Medal of Technology and Innovation

Medicine

For their fundamental invention of gene splicing techniques allowing replication in quantity of biomedically important new products, and beneficially transformed plant materials. This discovery of recombinant DNA technology has transformed the basic science of molecular biology and the biotechnology industry.

National Medal of Science

Biological Sciences

For his discovery of methods for propagating and expressing the hereditary information of DNA introduced into living cells, thereby enabling the cloning of individual genes and the study of their structure and function.

For their fundamental invention of gene splicing techniques allowing replication in quantity of biomedically important new products, and beneficially transformed plant materials. This discovery of recombinant DNA technology has transformed the basic science of molecular biology and the biotechnology industry.

For his discovery of methods for propagating and expressing the hereditary information of DNA introduced into living cells, thereby enabling the cloning of individual genes and the study of their structure and function.

VIEW STATISTICS +

Birth
February 17, 1935
Age Awarded
54 (Technology)
53 (Science)
Awarded With
Herbert W. Boyer (Technology)
Country of Birth
USA
Key Contributions
Research Developed Genetic Engineering
Awarded by
George H. W. Bush (Technology)
Ronald Wilson Reagan (Science)
Education
University of Pennsylvania
Rutgers University
Areas of Impact
Health & Medicine
Affiliations
Stanford University Medical Center
Other Prizes
National Inventors Hall of Fame
Lemelson-MIT Prize
A

As a child, Stanley N. Cohen was interested in science, especially in how things worked. He built and assembled telephones, radios, and was first interested in becoming a physicist. Cohen instead chose medicine, and during his residency became increasingly interested in research.

At Stanford, Cohen began to study bacterial plasmids with a goal to understand how the genes of plasmids could make bacteria resistant to antibiotics. Cohen met Herbert Boyer at a conference, and discussed various ways they could collaborate. Together, they developed the technique of recombinant DNA—taking genetic material from one organism and placing it in another organism where it is replicated and expressed.

Their research led to the new field of genetic engineering. Boyer and Cohen quickly recognized the feasibility of using bacteria with human genetic information was incorporated to duplicate the body’s natural means of fighting disease. Their work has led to breakthroughs in treatments, including the creation of synthetic insulin and human growth hormone. 

By Jen Santisi

...